Glycated albumin as a marker of glycemia in diabetes and its vascular complications

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2015, Vol 69, Issue 0

Abstract

Effective glycemic control is very important to prevent the onset and the progression of chronic complications in diabetic patients. It is known that glycation of various proteins is increased in diabetic patients compared with non-diabetics. Among these glycated proteins, glycated hemoglobin (HbA1c) is commonly used as a gold standard index of glycemic control in the clinical setting. However, it can be unreliable in conditions affecting the lifespan of erythrocytes (120 days) as well as in the clinical state in which glycemic control alleviates or deteriorates in a short period. By overcoming the shortcomings of HbA1c, glycated albumin (GA) has gained interest as a useful index for an intermediate glycation period (2 weeks) and pathogenic protein.After giving a brief overview of the key role of HbA1c as a long-term glycemic marker, this review focuses on (a) glycation of human albumin and its main properties, (b) methods of GA determination, (c) the recent clinical status of GA as a glycemic index in diabetic patients and its association with vascular complications. Finally, conditions with a possible inaccurate GA level are also mentioned.

Authors and Affiliations

Maria Warwas, Ewa Żurawska-Płaksej, Dagmara Ciężka, Agnieszka Piwowar

Keywords

Related Articles

Analysis of Vector Models in Quantification of Artifacts Produced by Standard Prosthetic Inlays in Cone-Beam Computed Tomography (CBCT) – a Preliminary Study

Cone-beam computed tomography (CBCT) is a relatively new, but highly efficient imaging method applied first in dentistry in 1998. However, the quality of the obtained slices depends among other things on artifacts genera...

Udział tkanki tłuszczowej w patogenezie i obrazie klinicznym orbitopatii tarczycowej

Orbitopatia tarczycowa jest zapalną chorobą tkanki łącznej o podłożu autoimmunologicznym traktowaną jako jeden z pozatarczycowych objawów choroby Gravesa i Basedowa. Mimo postępu w zrozumieniu niektórych elementów jej pa...

Leprosy – one of the many forgotten tropical diseases

Leprosy or Hansen disease is caused by an infection of Mycobacterium leprae. The large number of undetected cases (2000-2012 years 4 mln people) remains a threat to the elimination of leprosy. Leprosy is an unheard in Po...

Irisin – a new mediator of energy homeostasis

Skeletal muscles as an active hormonal compartment in the response of physical activity secrete substances named myokines capable of modulating metabolic processes. Myokines take part in communication between muscles and...

Sklerostyna i przewlekła choroba nerek

Przewlekła choroba nerek (PChN) prowadzi do zaburzeń mineralnych i kostnych, zwiększając częstość złamań, powikłań sercowo-naczyniowych i śmiertelność. Szlak sygnałowy Wnt/β-katenina odgrywa istotną rolę w rozwoju oraz p...

Download PDF file
  • EP ID EP67698
  • DOI -
  • Views 157
  • Downloads 0

How To Cite

Maria Warwas, Ewa Żurawska-Płaksej, Dagmara Ciężka, Agnieszka Piwowar (2015). Glycated albumin as a marker of glycemia in diabetes and its vascular complications. Advances in Hygiene and Experimental Medicine, 69(0), 638-648. https://europub.co.uk./articles/-A-67698